|
Volumn 33, Issue 9, 2002, Pages 2304-2310
|
Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia
|
Author keywords
Caspases; Cerebral ischemia, global; Magnetic resonance imaging; Neuroprotection; Reperfusion injury; Spectroscopy, nuclear magnetic resonance
|
Indexed keywords
2 IMINOBIOTIN;
CASPASE 3;
DRUG VEHICLE;
ISOENZYME;
NEUROPROTECTIVE AGENT;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE INHIBITOR;
NITROGEN DERIVATIVE;
REACTIVE NITROGEN SPECIES;
SODIUM CHLORIDE;
TYROSINE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
BRAIN CORTEX;
BRAIN EDEMA;
BRAIN ISCHEMIA;
BRAIN METABOLISM;
BRAIN NERVE CELL;
CELL STRUCTURE;
CONTROLLED STUDY;
ENERGY METABOLISM;
ENZYME ACTIVITY;
HISTOPATHOLOGY;
IMMUNOHISTOCHEMISTRY;
NEUROPROTECTION;
NEWBORN;
NEWBORN HYPOXIA;
NICK END LABELING;
NITRATION;
NONHUMAN;
PATHOPHYSIOLOGY;
PHOSPHORUS NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
REOXYGENATION;
REPERFUSION;
REPERFUSION INJURY;
SWINE;
TREATMENT OUTCOME;
ANIMALS;
ANIMALS, NEWBORN;
APOPTOSIS;
BIOTIN;
BRAIN;
BRAIN EDEMA;
CASPASE 3;
CASPASES;
DISEASE MODELS, ANIMAL;
ENERGY METABOLISM;
ENZYME INHIBITORS;
HYPOXIA-ISCHEMIA, BRAIN;
IMMUNOHISTOCHEMISTRY;
IN SITU NICK-END LABELING;
MAGNETIC RESONANCE SPECTROSCOPY;
NEUROPROTECTIVE AGENTS;
NITRIC OXIDE SYNTHASE;
REPERFUSION INJURY;
SURVIVAL RATE;
SWINE;
TREATMENT OUTCOME;
TYROSINE;
|
EID: 0036714560
PISSN: 00392499
EISSN: None
Source Type: Journal
DOI: 10.1161/01.STR.0000028343.25901.09 Document Type: Article |
Times cited : (109)
|
References (43)
|